Global Gabapentin Enacarbil Sales Market Report 2021

1 Gabapentin Enacarbil Market Overview

• 1.1 Gabapentin Enacarbil Product Scope
• 1.2 Gabapentin Enacarbil Segment by Type
  • 1.2.1 Global Gabapentin Enacarbil Sales by Type (2016 & 2021 & 2027)
  • 1.2.2 Capsule
  • 1.2.3 Tablet
• 1.3 Gabapentin Enacarbil Segment by Application
  • 1.3.1 Global Gabapentin Enacarbil Sales Comparison by Application (2016 & 2021 & 2027)
  • 1.3.2 Post-Herpetic Neuralgia (PHN)
  • 1.3.3 Restless Legs Syndrome (RLS)
  • 1.3.4 Others
• 1.4 Gabapentin Enacarbil Market Estimates and Forecasts (2016-2027)
  • 1.4.1 Global Gabapentin Enacarbil Market Size in Value Growth Rate (2016-2027)
  • 1.4.2 Global Gabapentin Enacarbil Market Size in Volume Growth Rate (2016-2027)
  • 1.4.3 Global Gabapentin Enacarbil Price Trends (2016-2027)

2 Gabapentin Enacarbil Estimates and Forecasts by Region

• 2.1 Global Gabapentin Enacarbil Market Size by Region: 2016 VS 2021 VS 2027
• 2.2 Global Gabapentin Enacarbil Retrospective Market Scenario by Region (2016-2021)
  • 2.2.1 Global Gabapentin Enacarbil Sales Market Share by Region (2016-2021)
  • 2.2.2 Global Gabapentin Enacarbil Revenue Market Share by Region (2016-2021)
• 2.3 Global Gabapentin Enacarbil Market Estimates and Forecasts by Region (2022-2027)
  • 2.3.1 Global Gabapentin Enacarbil Sales Estimates and Forecasts by Region (2022-2027)
  • 2.3.2 Global Gabapentin Enacarbil Revenue Forecast by Region (2022-2027)
• 2.4 Geographic Market Analysis: Market Facts & Figures
  • 2.4.1 North America Gabapentin Enacarbil Estimates and Projections (2016-2027)
  • 2.4.2 Europe Gabapentin Enacarbil Estimates and Projections (2016-2027)
  • 2.4.3 China Gabapentin Enacarbil Estimates and Projections (2016-2027)
  • 2.4.4 Japan Gabapentin Enacarbil Estimates and Projections (2016-2027)
  • 2.4.5 Southeast Asia Gabapentin Enacarbil Estimates and Projections (2016-2027)
  • 2.4.6 India Gabapentin Enacarbil Estimates and Projections (2016-2027)

3 Global Gabapentin Enacarbil Competition Landscape by Players

• 3.1 Global Top Gabapentin Enacarbil Players by Sales (2016-2021)
• 3.2 Global Top Gabapentin Enacarbil Players by Revenue (2016-2021)
• 3.3 Global Gabapentin Enacarbil Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Gabapentin Enacarbil as of 2020)
• 3.4 Global Gabapentin Enacarbil Average Price by Company (2016-2021)
• 3.5 Manufacturers Gabapentin Enacarbil Manufacturing Sites, Area Served, Product Type
• 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Gabapentin Enacarbil Market Size by Type

• 4.1 Global Gabapentin Enacarbil Historic Market Review by Type (2016-2021)
  • 4.1.1 Global Gabapentin Enacarbil Sales Market Share by Type (2016-2021)
  • 4.1.2 Global Gabapentin Enacarbil Revenue Market Share by Type (2016-2021)
  • 4.1.3 Global Gabapentin Enacarbil Price by Type (2016-2021)
• 4.2 Global Gabapentin Enacarbil Market Estimates and Forecasts by Type (2022-2027)
  • 4.2.1 Global Gabapentin Enacarbil Sales Forecast by Type (2022-2027)
  • 4.2.2 Global Gabapentin Enacarbil Revenue Forecast by Type (2022-2027)
  • 4.2.3 Global Gabapentin Enacarbil Price Forecast by Type (2022-2027)

5 Global Gabapentin Enacarbil Market Size by Application

• 5.1 Global Gabapentin Enacarbil Historic Market Review by Application (2016-2021)
  • 5.1.1 Global Gabapentin Enacarbil Sales Market Share by Application (2016-2021)
  • 5.1.2 Global Gabapentin Enacarbil Revenue Market Share by Application (2016-2021)
  • 5.1.3 Global Gabapentin Enacarbil Price by Application (2016-2021)
• 5.2 Global Gabapentin Enacarbil Market Estimates and Forecasts by Application (2022-2027)
  • 5.2.1 Global Gabapentin Enacarbil Sales Forecast by Application (2022-2027)
  • 5.2.2 Global Gabapentin Enacarbil Revenue Forecast by Application (2022-2027)
  • 5.2.3 Global Gabapentin Enacarbil Price Forecast by Application (2022-2027)

6 North America Gabapentin Enacarbil Market Facts & Figures

• 6.1 North America Gabapentin Enacarbil Sales by Company
  • 6.1.1 North America Gabapentin Enacarbil Sales by Company (2016-2021)
  • 6.1.2 North America Gabapentin Enacarbil Revenue by Company (2016-2021)
• 6.2 North America Gabapentin Enacarbil Sales Breakdown by Type
  • 6.2.1 North America Gabapentin Enacarbil Sales Breakdown by Type (2016-2021)
  • 6.2.2 North America Gabapentin Enacarbil Sales Breakdown by Type (2022-2027)
• 6.3 North America Gabapentin Enacarbil Sales Breakdown by Application
  • 6.3.1 North America Gabapentin Enacarbil Sales Breakdown by Application (2016-2021)
  • 6.3.2 North America Gabapentin Enacarbil Sales Breakdown by Application (2022-2027)

7 Europe Gabapentin Enacarbil Market Facts & Figures

• 7.1 Europe Gabapentin Enacarbil Sales by Company
  • 7.1.1 Europe Gabapentin Enacarbil Sales by Company (2016-2021)
  • 7.1.2 Europe Gabapentin Enacarbil Revenue by Company (2016-2021)
• 7.2 Europe Gabapentin Enacarbil Sales Breakdown by Type
  • 7.2.1 Europe Gabapentin Enacarbil Sales Breakdown by Type (2016-2021)
  • 7.2.2 Europe Gabapentin Enacarbil Sales Breakdown by Type (2022-2027)
• 7.3 Europe Gabapentin Enacarbil Sales Breakdown by Application
  • 7.3.1 Europe 142 Sales Breakdown by Application (2016-2021)
  • 7.3.2 Europe 142 Sales Breakdown by Application (2022-2027)

8 China Gabapentin Enacarbil Market Facts & Figures

• 8.1 China Gabapentin Enacarbil Sales by Company
  • 8.1.1 China Gabapentin Enacarbil Sales by Company (2016-2021)
  • 8.1.2 China Gabapentin Enacarbil Revenue by Company (2016-2021)
• 8.2 China Gabapentin Enacarbil Sales Breakdown by Type
  • 8.2.1 China Gabapentin Enacarbil Sales Breakdown by Type (2016-2021)
  • 8.2.2 China Gabapentin Enacarbil Sales Breakdown by Type (2022-2027)
• 8.3 China Gabapentin Enacarbil Sales Breakdown by Application
  • 8.3.1 China 312 Sales Breakdown by Application (2016-2021)
  • 8.3.2 China 312 Sales Breakdown by Application (2022-2027)

9 Japan Gabapentin Enacarbil Market Facts & Figures

• 9.1 Japan Gabapentin Enacarbil Sales by Company
  • 9.1.1 Japan Gabapentin Enacarbil Sales by Company (2016-2021)
  • 9.1.2 Japan Gabapentin Enacarbil Revenue by Company (2016-2021)
• 9.2 Japan Gabapentin Enacarbil Sales Breakdown by Type
  • 9.2.1 Japan Gabapentin Enacarbil Sales Breakdown by Type (2016-2021)
  • 9.2.2 Japan Gabapentin Enacarbil Sales Breakdown by Type (2022-2027)
• 9.3 Japan Gabapentin Enacarbil Sales Breakdown by Application
  • 9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
  • 9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Gabapentin Enacarbil Market Facts & Figures

• 10.1 Southeast Asia Gabapentin Enacarbil Sales by Company
  • 10.1.1 Southeast Asia Gabapentin Enacarbil Sales by Company (2016-2021)
  • 10.1.2 Southeast Asia Gabapentin Enacarbil Revenue by Company (2016-2021)
• 10.2 Southeast Asia Gabapentin Enacarbil Sales Breakdown by Type
  • 10.2.1 Southeast Asia Gabapentin Enacarbil Sales Breakdown by Type (2016-2021)
  • 10.2.2 Southeast Asia Gabapentin Enacarbil Sales Breakdown by Type (2022-2027)
• 10.3 Southeast Asia Gabapentin Enacarbil Sales Breakdown by Application
  • 10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
  • 10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)

11 India Gabapentin Enacarbil Market Facts & Figures

• 11.1 India Gabapentin Enacarbil Sales by Company
  • 11.1.1 India Gabapentin Enacarbil Sales by Company (2016-2021)
  • 11.1.2 India Gabapentin Enacarbil Revenue by Company (2016-2021)
• 11.2 India Gabapentin Enacarbil Sales Breakdown by Type
  • 11.2.1 India Gabapentin Enacarbil Sales Breakdown by Type (2016-2021)
  • 11.2.2 India Gabapentin Enacarbil Sales Breakdown by Type (2022-2027)
• 11.3 India Gabapentin Enacarbil Sales Breakdown by Application
  • 11.3.1 India Gabapentin Enacarbil Sales Breakdown by Application (2016-2021)
  • 11.3.2 India Gabapentin Enacarbil Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Gabapentin Enacarbil Business

• 12.1 Arbor Pharma
  • 12.1.1 Arbor Pharma Corporation Information
  • 12.1.2 Arbor Pharma Business Overview
  • 12.1.3 Arbor Pharma Gabapentin Enacarbil Sales, Revenue and Gross Margin (2016-2021)
  • 12.1.4 Arbor Pharma Gabapentin Enacarbil Products Offered
  • 12.1.5 Arbor Pharma Recent Development
• 12.2 Astellas
  • 12.2.1 Astellas Corporation Information
  • 12.2.2 Astellas Business Overview
  • 12.2.3 Astellas Gabapentin Enacarbil Sales, Revenue and Gross Margin (2016-2021)
  • 12.2.4 Astellas Gabapentin Enacarbil Products Offered
  • 12.2.5 Astellas Recent Development
• 12.3 GlaxoSmithKline
  • 12.3.1 GlaxoSmithKline Corporation Information
  • 12.3.2 GlaxoSmithKline Business Overview
  • 12.3.3 GlaxoSmithKline Gabapentin Enacarbil Sales, Revenue and Gross Margin (2016-2021)
  • 12.3.4 GlaxoSmithKline Gabapentin Enacarbil Products Offered
  • 12.3.5 GlaxoSmithKline Recent Development
• 12.4 Glenmark Pharma
  • 12.4.1 Glenmark Pharma Corporation Information
  • 12.4.2 Glenmark Pharma Business Overview
  • 12.4.3 Glenmark Pharma Gabapentin Enacarbil Sales, Revenue and Gross Margin (2016-2021)
  • 12.4.4 Glenmark Pharma Gabapentin Enacarbil Products Offered
  • 12.4.5 Glenmark Pharma Recent Development
• 12.5 Pfizer
  • 12.5.1 Pfizer Corporation Information
  • 12.5.2 Pfizer Business Overview
  • 12.5.3 Pfizer Gabapentin Enacarbil Sales, Revenue and Gross Margin (2016-2021)
  • 12.5.4 Pfizer Gabapentin Enacarbil Products Offered
  • 12.5.5 Pfizer Recent Development
• 12.6 Depomed
  • 12.6.1 Depomed Corporation Information
  • 12.6.2 Depomed Business Overview
  • 12.6.3 Depomed Gabapentin Enacarbil Sales, Revenue and Gross Margin (2016-2021)
  • 12.6.4 Depomed Gabapentin Enacarbil Products Offered
  • 12.6.5 Depomed Recent Development
• 12.7 Teva
  • 12.7.1 Teva Corporation Information
  • 12.7.2 Teva Business Overview
  • 12.7.3 Teva Gabapentin Enacarbil Sales, Revenue and Gross Margin (2016-2021)
  • 12.7.4 Teva Gabapentin Enacarbil Products Offered
  • 12.7.5 Teva Recent Development
• 12.8 Mylan
  • 12.8.1 Mylan Corporation Information
  • 12.8.2 Mylan Business Overview
  • 12.8.3 Mylan Gabapentin Enacarbil Sales, Revenue and Gross Margin (2016-2021)
  • 12.8.4 Mylan Gabapentin Enacarbil Products Offered
  • 12.8.5 Mylan Recent Development
• 12.9 Novartis
  • 12.9.1 Novartis Corporation Information
  • 12.9.2 Novartis Business Overview
  • 12.9.3 Novartis Gabapentin Enacarbil Sales, Revenue and Gross Margin (2016-2021)
  • 12.9.4 Novartis Gabapentin Enacarbil Products Offered
  • 12.9.5 Novartis Recent Development
• 12.10 Apotex
  • 12.10.1 Apotex Corporation Information
  • 12.10.2 Apotex Business Overview
  • 12.10.3 Apotex Gabapentin Enacarbil Sales, Revenue and Gross Margin (2016-2021)
  • 12.10.4 Apotex Gabapentin Enacarbil Products Offered
  • 12.10.5 Apotex Recent Development
• 12.11 Sun Pharmaceutical
  • 12.11.1 Sun Pharmaceutical Corporation Information
  • 12.11.2 Sun Pharmaceutical Business Overview
  • 12.11.3 Sun Pharmaceutical Gabapentin Enacarbil Sales, Revenue and Gross Margin (2016-2021)
  • 12.11.4 Sun Pharmaceutical Gabapentin Enacarbil Products Offered
  • 12.11.5 Sun Pharmaceutical Recent Development
• 12.12 Aurobindo Pharma
  • 12.12.1 Aurobindo Pharma Corporation Information
  • 12.12.2 Aurobindo Pharma Business Overview
  • 12.12.3 Aurobindo Pharma Gabapentin Enacarbil Sales, Revenue and Gross Margin (2016-2021)
  • 12.12.4 Aurobindo Pharma Gabapentin Enacarbil Products Offered
  • 12.12.5 Aurobindo Pharma Recent Development
• 12.13 Intas
  • 12.13.1 Intas Corporation Information
  • 12.13.2 Intas Business Overview
  • 12.13.3 Intas Gabapentin Enacarbil Sales, Revenue and Gross Margin (2016-2021)
  • 12.13.4 Intas Gabapentin Enacarbil Products Offered
  • 12.13.5 Intas Recent Development
• 12.14 Amneal
  • 12.14.1 Amneal Corporation Information
  • 12.14.2 Amneal Business Overview
  • 12.14.3 Amneal Gabapentin Enacarbil Sales, Revenue and Gross Margin (2016-2021)
  • 12.14.4 Amneal Gabapentin Enacarbil Products Offered
  • 12.14.5 Amneal Recent Development
• 12.15 Marksans Pharma
  • 12.15.1 Marksans Pharma Corporation Information
  • 12.15.2 Marksans Pharma Business Overview
  • 12.15.3 Marksans Pharma Gabapentin Enacarbil Sales, Revenue and Gross Margin (2016-2021)
  • 12.15.4 Marksans Pharma Gabapentin Enacarbil Products Offered
  • 12.15.5 Marksans Pharma Recent Development
• 12.16 Alkem
  • 12.16.1 Alkem Corporation Information
  • 12.16.2 Alkem Business Overview
  • 12.16.3 Alkem Gabapentin Enacarbil Sales, Revenue and Gross Margin (2016-2021)
  • 12.16.4 Alkem Gabapentin Enacarbil Products Offered
  • 12.16.5 Alkem Recent Development
• 12.17 Jiangsu Enhua
  • 12.17.1 Jiangsu Enhua Corporation Information
  • 12.17.2 Jiangsu Enhua Business Overview
  • 12.17.3 Jiangsu Enhua Gabapentin Enacarbil Sales, Revenue and Gross Margin (2016-2021)
  • 12.17.4 Jiangsu Enhua Gabapentin Enacarbil Products Offered
  • 12.17.5 Jiangsu Enhua Recent Development
• 12.18 Jiangsu Hengrui
  • 12.18.1 Jiangsu Hengrui Corporation Information
  • 12.18.2 Jiangsu Hengrui Business Overview
  • 12.18.3 Jiangsu Hengrui Gabapentin Enacarbil Sales, Revenue and Gross Margin (2016-2021)
  • 12.18.4 Jiangsu Hengrui Gabapentin Enacarbil Products Offered
  • 12.18.5 Jiangsu Hengrui Recent Development
• 12.19 Sailike Pharma
  • 12.19.1 Sailike Pharma Corporation Information
  • 12.19.2 Sailike Pharma Business Overview
  • 12.19.3 Sailike Pharma Gabapentin Enacarbil Sales, Revenue and Gross Margin (2016-2021)
  • 12.19.4 Sailike Pharma Gabapentin Enacarbil Products Offered
  • 12.19.5 Sailike Pharma Recent Development

13 Gabapentin Enacarbil Manufacturing Cost Analysis

• 13.1 Gabapentin Enacarbil Key Raw Materials Analysis
  • 13.1.1 Key Raw Materials
  • 13.1.2 Key Raw Materials Price Trend
  • 13.1.3 Key Suppliers of Raw Materials
• 13.2 Proportion of Manufacturing Cost Structure
• 13.3 Manufacturing Process Analysis of Gabapentin Enacarbil
• 13.4 Gabapentin Enacarbil Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers

• 14.1 Marketing Channel
• 14.2 Gabapentin Enacarbil Distributors List
• 14.3 Gabapentin Enacarbil Customers

15 Market Dynamics

• 15.1 Gabapentin Enacarbil Market Trends
• 15.2 Gabapentin Enacarbil Drivers
• 15.3 Gabapentin Enacarbil Market Challenges
• 15.4 Gabapentin Enacarbil Market Restraints

16 Research Findings and Conclusion

17 Appendix

• 17.1 Research Methodology
  • 17.1.1 Methodology/Research Approach
  • 17.1.2 Data Source
• 17.2 Author List